Standout Papers

<i>TET2</i>-Driven Clonal Hematopoiesis and Response to Canakinumab 2022 2026 2023 2024195
  1. TET2-Driven Clonal Hematopoiesis and Response to Canakinumab (2022)
    E. C. Svensson, Aviv Madar et al. JAMA Cardiology

Immediate Impact

1 by Nobel laureates 23 from Science/Nature 92 standout
Sub-graph 1 of 20

Citing Papers

Frailty in Older Adults
2024 Standout
Natural killer cell therapies
2024 StandoutNature
2 intermediate papers

Works of Aviv Madar being referenced

TET2-Driven Clonal Hematopoiesis and Response to Canakinumab
2022 Standout
ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells
2014

Author Peers

Author Last Decade Papers Cites
Aviv Madar 610 406 255 16 1.2k
Sonny Ang 599 785 353 20 1.6k
Zinaida Good 683 672 443 14 1.4k
Travis Law 943 287 239 8 1.2k
Hiro Shimada 675 529 296 14 1.6k
Xiuhua Gao 402 549 479 23 1.1k
Edahí González‐Avalos 668 520 679 14 1.3k
Jenny J. Hong 606 784 438 23 1.4k
Kristoffer Weber 707 430 121 17 1.1k
Luca Biasco 745 430 289 29 1.2k
Andrew Tri Van Ho 810 219 135 24 1.3k

All Works

Loading papers...

Rankless by CCL
2026